Dingdang Health Technology Group Ltd
HKEX:9886
Intrinsic Value
Dingdang Health Technology Group Ltd. is an investment holding company, which engages in the provision of pharmaceutical and healthcare solutions. [ Read More ]
The intrinsic value of one Dingdang Health Technology Group Ltd stock under the Base Case scenario is 1.1 HKD. Compared to the current market price of 1.3 HKD, Dingdang Health Technology Group Ltd is Overvalued by 16%.
Valuation Backtest
Dingdang Health Technology Group Ltd
Run backtest to discover the historical profit from buying and selling Dingdang Health Technology Group Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Dingdang Health Technology Group Ltd
| Current Assets | 2.5B |
| Cash & Short-Term Investments | 1.3B |
| Receivables | 407.3m |
| Other Current Assets | 772.5m |
| Non-Current Assets | 769.9m |
| Long-Term Investments | 116.2m |
| PP&E | 217.4m |
| Intangibles | 425.7m |
| Other Non-Current Assets | 10.6m |
| Current Liabilities | 969.3m |
| Accounts Payable | 345.9m |
| Accrued Liabilities | 265.7m |
| Other Current Liabilities | 357.7m |
| Non-Current Liabilities | 142.5m |
| Long-Term Debt | 91m |
| Other Non-Current Liabilities | 51.5m |
Earnings Waterfall
Dingdang Health Technology Group Ltd
|
Revenue
|
4.9B
CNY
|
|
Cost of Revenue
|
-3.3B
CNY
|
|
Gross Profit
|
1.5B
CNY
|
|
Operating Expenses
|
-1.7B
CNY
|
|
Operating Income
|
-220.4m
CNY
|
|
Other Expenses
|
-5.5m
CNY
|
|
Net Income
|
-225.8m
CNY
|
Free Cash Flow Analysis
Dingdang Health Technology Group Ltd
Profitability Score
Profitability Due Diligence
Dingdang Health Technology Group Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
Dingdang Health Technology Group Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Dingdang Health Technology Group Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Score
Dingdang Health Technology Group Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Dingdang Health Technology Group Ltd
According to Wall Street analysts, the average 1-year price target for Dingdang Health Technology Group Ltd is 1.51 HKD with a low forecast of 1.49 HKD and a high forecast of 1.55 HKD.
Shareholder Return
Price
Dingdang Health Technology Group Ltd
| Average Annual Return | -4.17% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -92% |
| Market Capitalization | 1.7B HKD |
| Shares Outstanding | 1 333 822 900 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dingdang Health Technology Group Ltd. is an investment holding company, which engages in the provision of pharmaceutical and healthcare solutions. The company is headquartered in Beijing, Beijing and currently employs 2,933 full-time employees. The company went IPO on 2022-09-14. The firm operates two segments. The Pharmaceutical and Healthcare Business segment is engaged in online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. The Others segment provides marketing services, marketplace services and other services. The firm mainly conducts businesses within the domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one Dingdang Health Technology Group Ltd stock under the Base Case scenario is 1.1 HKD.
Compared to the current market price of 1.3 HKD, Dingdang Health Technology Group Ltd is Overvalued by 16%.
You don't have any saved screeners yet
